Get the Stockscreener App
5.19
2.57%
0.13
Pre-market:
5.11
-0.08
-1.54%
Avita Medical Inc stock is traded at $5.19, with a volume of 385.90K.
It is up +2.57% in the last 24 hours and up +24.16% over the past month.
Avita is largely a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently used in most of the 140 US burn centers. Despite having product approval in Australia, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region, although international sales, particularly in Japan, are growing. Avita is domiciled, and has its primary listing, in the US.
See More
Previous Close:
$5.06
Open:
$4.96
24h Volume:
385.90K
Relative Volume:
1.39
Market Cap:
$159.73M
Revenue:
$72.35M
Net Income/Loss:
$-45.34M
P/E Ratio:
-3.3047
EPS:
-1.5705
Net Cash Flow:
$-32.43M
1W Performance:
+22.12%
1M Performance:
+24.16%
6M Performance:
+51.75%
1Y Performance:
-4.24%
1-Day Range:
$4.80
$5.23
1-Week Range:
$4.01
$5.23
52-Week Range:
$3.22
$7.12
Avita Medical Inc Stock (RCEL) Company Profile
Name
Avita Medical Inc
Sector
Industry
Phone
661-568-1317
Address
28159 AVENUE STANFORD, VALENCIA, CA
Compare RCEL vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RCEL
Avita Medical Inc
|
5.19 | 127.11M | 72.35M | -45.34M | -32.43M | -1.5705 |
ABT
Abbott Laboratories
|
95.63 | 158.05B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
324.73 | 120.70B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
83.06 | 100.14B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
44.60 | 63.44B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
95.18 | 52.09B | 6.30B | 1.07B | 1.09B | 1.8406 |
Avita Medical Inc Stock (RCEL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-05-26 | Initiated | Northland Capital | Outperform |
| Nov-20-25 | Upgrade | BTIG Research | Sell → Neutral |
| Aug-08-25 | Downgrade | BTIG Research | Neutral → Sell |
| Dec-24-24 | Initiated | D. Boral Capital | Buy |
| Apr-11-24 | Downgrade | BTIG Research | Buy → Neutral |
| Jun-27-23 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-02-21 | Initiated | Piper Sandler | Overweight |
| Aug-27-20 | Initiated | BofA Securities | Buy |
| Apr-21-20 | Initiated | Oppenheimer | Outperform |
| Mar-03-20 | Initiated | BTIG Research | Buy |
View All
Avita Medical Inc Stock (RCEL) Latest News
Price to sales forward of AVITA Medical Inc Shs Chess Depository Interests repr 0.2 shs – ASX:AVH - TradingView
AVITA Medical, Inc.(NasdaqCM:RCEL) dropped from Russell Small Cap Comp Growth Benchmark - marketscreener.com
AVITA Medical, Inc.(NasdaqCM: RCEL) dropped from Russell 2500 Growth Benchmark - marketscreener.com
AVITA Medical, Inc.(NasdaqCM: RCEL) dropped from Russell 2000 Growth Benchmark - marketscreener.com
AVITA Medical, Inc.(NasdaqCM: RCEL) dropped from Russell 2000 Dynamic Index - marketscreener.com
AVITA Medical, Inc.(NasdaqCM: RCEL) dropped from Russell 3000E Index - marketscreener.com
AVITA Medical, Inc.(NasdaqCM: RCEL) dropped from Russell 2500 Index - marketscreener.com
AVITA Medical, Inc.(NasdaqCM: RCEL) dropped from Russell 3000 Index - marketscreener.com
Bronstein, Gewirtz & Grossman, LLC Is Investigating AVITA Medical - The National Law Review
AVITA Medical Inc (RCEL) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Price to book forward of AVITA Medical Inc – LS:A2P733 - TradingView
Price to sales forward of Avita Medical, Inc. – NASDAQ:RCEL - TradingView
BTIG Maintains Avita Medical(RCEL.US) With Hold Rating - Moomoo
AVITA Medical Inc (RCEL) Valuation: PE, PB & Fair Value Analysis - TradingKey
AVITA Medical Inc (RCEL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
AVITA Medical (RCEL) Showcases RECELL GO Clinical Data at UK Con - GuruFocus
AVITA Medical Highlights First U.K. Clinical Experience with RECELL GO at British Burn Association Annual Meeting - Investing News Network
AVITA Medical’s burn treatment used in 17 U.K. patients - Stock Titan
AVITA Medical Inc (RCEL) Institutional Confidence - TradingKey
AVITA Medical Inc (RCEL) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
AVITA Medical Inc (RCEL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
AVITA Medical Inc (RCEL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
AVITA Medical Inc (RCEL) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
AVITA Medical Inc (RCEL) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
RCEL to Host Virtual Meeting on June 23 - GuruFocus
AVITA Medical (RCEL) CFO receives 2,000-share equity grant in Form 4 - Stock Titan
Insider Buying: Joseph Woody Acquires Shares of AVITA Medical In - GuruFocus
Avita Medical director Woody Fralin buys $20,800 in common stock - Investing.com
Avita Medical director Woody Fralin buys $20,800 in common stock By Investing.com - Investing.com India
AVITA Medical (RCEL) director adds 5,200 shares in open-market buy - Stock Titan
Avita Medical director Woody Fralin buys $41,900 in stock By Investing.com - Investing.com India
Avita Medical director Woody Fralin buys $41,900 in stock - Investing.com
Insider Buying: Joseph Woody Acquires 10,000 Shares of AVITA Med - GuruFocus
Director Woody Fralin buys 10,000 AVITA Medical (RCEL) shares - Stock Titan
AVITA Medical, Inc. Issues Warrant Certificate to Perceptive Credit Holdings V, LP – Details, Terms, and Signatures - Minichart
AVITA Medical Issues Warrant to Perceptive Tied to $60 Million Credit Facility - TradingView
[8-K] AVITA Medical, Inc. Reports Material Event - Stock Titan
AVITA Medical (RCEL) registers 650,000 shares tied to Perceptive $3.40 warrant - Stock Titan
AVITA Medical (RCEL) director makes 10,000-share open-market stock purchase - Stock Titan
AVITA Medical Stock Is Moving: Shareholder Votes Put Cash, Warrants and Wound-Care Growth in Focus - Bez Kabli
AVITA Medical (RCEL) director receives RSU and stock option awards - Stock Titan
AVITA Medical (NASDAQ: RCEL) grants RSUs and stock options to director - Stock Titan
AVITA Medical (RCEL) director Michael Tarnoff receives RSU and option grants - Stock Titan
AVITA Medical (RCEL) director receives RSU and option awards in equity grant - Stock Titan
AVITA Medical (RCEL) director Suzanne Crowe granted RSUs and stock options - Stock Titan
Director at AVITA Medical (NASDAQ: RCEL) granted RSUs and options - Stock Titan
Avita Medical, Inc. Ratifies Appointment of Grant Thornton LLP as Independent Registered Public Accounting Firm - marketscreener.com
Insider Buying: Joseph Woody Acquires 20,000 Shares of AVITA Med - GuruFocus
AVITA MEDICAL INC-2026 ASM BOARD CHAIR SCRIPT - Moomoo
AVITA Medical (NASDAQ: RCEL) investors approve director pay, warrants and extra equity capacity - Stock Titan
Director Woody Fralin buys 20,000 AVITA Medical (RCEL) shares - Stock Titan
Avita Medical Inc Stock (RCEL) Financials Data
Revenue
Net Income
Cash Flow
EPS
Avita Medical Inc Stock (RCEL) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Woody Joseph Fralin | Director |
Jun 09 '26 |
Buy |
4.19 |
10,000 |
41,900 |
102,761 |
| Woody Joseph Fralin | Director |
Jun 03 '26 |
Buy |
4.09 |
10,000 |
40,949 |
92,761 |
| Woody Joseph Fralin | Director |
Jun 01 '26 |
Buy |
4.30 |
10,000 |
43,000 |
10,000 |
| Woody Joseph Fralin | Director |
Jun 02 '26 |
Buy |
4.19 |
10,000 |
41,936 |
20,000 |
| O'Toole David D | CFO |
May 20 '26 |
Buy |
4.26 |
2,000 |
8,520 |
145,927 |
| O'Toole David D | CFO |
May 19 '26 |
Buy |
4.24 |
2,000 |
8,480 |
143,927 |
| O'Toole David D | CFO |
Feb 19 '26 |
Buy |
4.15 |
3,000 |
12,450 |
140,127 |
| McNamara Robert | Director |
Aug 28 '25 |
Buy |
4.50 |
10,000 |
45,000 |
86,771 |
| O'Toole David D | CFO |
Aug 26 '25 |
Buy |
4.52 |
2,000 |
9,040 |
31,657 |
| McNamara Robert | Director |
Aug 19 '25 |
Buy |
5.00 |
10,000 |
50,000 |
76,771 |
2.62%
2.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):